MA26786A1 - Nouveau produit pharmaceutique. - Google Patents

Nouveau produit pharmaceutique.

Info

Publication number: MA26786A1
Authority: MA; Morocco
Prior art keywords: pharmaceutical product; new pharmaceutical; new; product; pharmaceutical
Prior art date: 1999-04-23

Application number

MA26379A

Other languages

English (en)

Inventor

Paul David James Blackler

Robert Gordon Giles

Michael John Sasse

Stephen Moore

Original Assignee

Smithkline Beecham Plc

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1999-04-23

Filing date

2001-10-22

Publication date

2004-12-20

1999-04-23 Priority claimed from GBGB9909471.6A external-priority patent/GB9909471D0/en

1999-05-25 Priority claimed from GBGB9912195.6A external-priority patent/GB9912195D0/en

2001-10-22 Application filed by Smithkline Beecham Plc filed Critical Smithkline Beecham Plc

2004-12-20 Publication of MA26786A1 publication Critical patent/MA26786A1/fr

Links

239000000825 pharmaceutical preparation Substances 0.000 title 1
229940127557 pharmaceutical product Drugs 0.000 title 1

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
- C07D417/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/425—Thiazoles
- A61K31/427—Thiazoles not condensed and containing further heterocyclic rings
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Diabetes (AREA)
Medicinal Chemistry (AREA)
Veterinary Medicine (AREA)
Public Health (AREA)
General Health & Medical Sciences (AREA)
Animal Behavior & Ethology (AREA)
Life Sciences & Earth Sciences (AREA)
Pharmacology & Pharmacy (AREA)
Hematology (AREA)
Endocrinology (AREA)
General Chemical & Material Sciences (AREA)
Chemical Kinetics & Catalysis (AREA)
Obesity (AREA)
Bioinformatics & Cheminformatics (AREA)
Engineering & Computer Science (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Emergency Medicine (AREA)
Epidemiology (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Plural Heterocyclic Compounds (AREA)
Steroid Compounds (AREA)
Thiazole And Isothizaole Compounds (AREA)

MA26379A 1999-04-23 2001-10-22 Nouveau produit pharmaceutique. MA26786A1 (fr)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
GBGB9909471.6A GB9909471D0 (en)	1999-04-23	1999-04-23	Novel compounds
GBGB9912195.6A GB9912195D0 (en)	1999-05-25	1999-05-25	Novel pharmaceutical

Publications (1)

Publication Number	Publication Date
MA26786A1 true MA26786A1 (fr)	2004-12-20

Family

ID=26315459

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
MA26379A MA26786A1 (fr)	1999-04-23	2001-10-22	Nouveau produit pharmaceutique.

Country Status (36)

Country	Link
EP (2)	EP1175418A2 (fr)
JP (1)	JP2002543076A (fr)
KR (1)	KR100744361B1 (fr)
CN (1)	CN1152878C (fr)
AP (1)	AP1607A (fr)
AR (2)	AR023750A1 (fr)
AU (2)	AU4307200A (fr)
BG (1)	BG65517B1 (fr)
BR (1)	BR0009935A (fr)
CA (1)	CA2370262A1 (fr)
CO (1)	CO5170419A1 (fr)
CZ (1)	CZ20013801A3 (fr)
DZ (1)	DZ3164A1 (fr)
EA (1)	EA003031B1 (fr)
EG (1)	EG23937A (fr)
GC (1)	GC0000250A (fr)
HK (1)	HK1045152A1 (fr)
HR (1)	HRP20010774A2 (fr)
HU (1)	HUP0200937A3 (fr)
IL (1)	IL146115A0 (fr)
MA (1)	MA26786A1 (fr)
MX (1)	MXPA01010822A (fr)
MY (1)	MY138673A (fr)
NO (1)	NO320587B1 (fr)
NZ (1)	NZ515167A (fr)
OA (1)	OA11873A (fr)
PE (1)	PE20010045A1 (fr)
PL (1)	PL351685A1 (fr)
SK (1)	SK14932001A3 (fr)
TR (1)	TR200103060T2 (fr)
TW (1)	TWI288749B (fr)
UA (1)	UA67845C2 (fr)
UY (1)	UY26119A1 (fr)
WO (1)	WO2000064893A2 (fr)
YU (1)	YU75401A (fr)
ZA (1)	ZA200108718B (fr)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US6664278B2 (en)	1997-12-16	2003-12-16	Smithkline Beecham P.L.C.	Hydrate of 5-[4-[2-(N-methyl-N-(2-pyridil)amino)ethoxy]benzyl]thiazolidine-2,4-dione maleic acid salt
US20020137940A1 (en)	1997-12-16	2002-09-26	Smithkline Beecham P.L.C.	5-[4-[2-(N-methyl-N-(2-pyridyl)amino)ethoxy]benzyl]thiazolidine-2, 4-dione, maleic acid salt, hydrate as pharmaceutical
GB9726568D0 (en)	1997-12-16	1998-02-11	Smithkline Beecham Plc	Novel pharmaceutical
JP2002541785A (ja) *	1999-04-13	2002-12-10	アメリカ合衆国	クローン化ヌクレオチド配列からの弱毒化キメラ呼吸系発疹ウイルスワクチンの製造
UA67844C2 (uk)	1999-04-23	2004-07-15	Смітклайн Бічам Плс	Поліморф 5-[4-[2-(n-метил-n-(2-піридил)аміно)етокси]бензил]тіазолідин-2,4-діону солі малеїнової кислоти
DE60004658T2 (de)	1999-04-23	2004-06-24	Smithkline Beecham Plc, Brentford	Thiazolidindionderivat und seine verwendung als antidiabetikum
GB0006133D0 (en)	2000-03-14	2000-05-03	Smithkline Beecham Plc	Novel pharmaceutical
US7241895B2 (en) *	2000-09-26	2007-07-10	Dr. Reddy's Laboratories Limited	Polymorphic forms of 5-[4-[2-[n-methyl-n-(2-pyridyl)amino[ethoxy]benzyl] thiazolidine-2,4-dione maleate and process for their preparation
WO2004062667A1 (fr) *	2003-01-08	2004-07-29	Dr. Reddy's Laboratories Limited	Forme amorphe du maleate de rosiglitazone et procede de preparation
GB0307259D0 (en) *	2003-03-28	2003-05-07	Glaxo Group Ltd	Process
EP1468997A3 (fr) *	2003-04-18	2004-11-03	CHEMI S.p.A.	Formes polymorphes de maléate de rosiglitatone
GB2405403A (en) *	2003-08-29	2005-03-02	Cipla Ltd	Rosiglitazone maleate of particular polymorphic forms and methods of preparing rosiglitazone free base
ITMI20041537A1 (it) *	2004-07-28	2004-10-28	Chemi Spa	Nuova forma polimorfa del rosiglitazone maleato
CZ298424B6 (cs) *	2005-05-24	2007-09-26	Zentiva, A. S.	Zpusob krystalizace rosiglitazonu a jeho derivátuze smesných rozpouštedel
TW200838512A (en) *	2007-02-08	2008-10-01	Daiichi Sankyo Co Ltd	Crystalline forms of a thiazolidinedione compound and manufacturing methods thereof

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
SG59988A1 (en) *	1987-09-04	1999-02-22	Beecham Group Plc	Substituted thiazolidinedione derivatives
GB9218830D0 (en) *	1992-09-05	1992-10-21	Smithkline Beecham Plc	Novel compounds
GB9726566D0 (en) *	1997-12-16	1998-02-11	Smithkline Beecham Plc	Novel pharmaceutical
GB9726563D0 (en) *	1997-12-16	1998-02-11	Smithkline Beecham Plc	Novel pharmaceutical
GB9726568D0 (en) *	1997-12-16	1998-02-11	Smithkline Beecham Plc	Novel pharmaceutical

2000
- 2000-04-19 PL PL00351685A patent/PL351685A1/xx not_active Application Discontinuation
- 2000-04-19 YU YU75401A patent/YU75401A/sh unknown
- 2000-04-19 DZ DZ003164A patent/DZ3164A1/fr active
- 2000-04-19 HU HU0200937A patent/HUP0200937A3/hu unknown
- 2000-04-19 CO CO00028927A patent/CO5170419A1/es not_active Application Discontinuation
- 2000-04-19 CA CA002370262A patent/CA2370262A1/fr not_active Abandoned
- 2000-04-19 JP JP2000614245A patent/JP2002543076A/ja active Pending
- 2000-04-19 PE PE2000000363A patent/PE20010045A1/es not_active Application Discontinuation
- 2000-04-19 WO PCT/GB2000/001522 patent/WO2000064893A2/fr not_active Ceased
- 2000-04-19 BR BR0009935-0A patent/BR0009935A/pt not_active Application Discontinuation
- 2000-04-19 EP EP00922793A patent/EP1175418A2/fr not_active Withdrawn
- 2000-04-19 NZ NZ515167A patent/NZ515167A/xx unknown
- 2000-04-19 IL IL14611500A patent/IL146115A0/xx unknown
- 2000-04-19 AR ARP000101866A patent/AR023750A1/es unknown
- 2000-04-19 TR TR2001/03060T patent/TR200103060T2/xx unknown
- 2000-04-19 KR KR1020017013592A patent/KR100744361B1/ko not_active Expired - Fee Related
- 2000-04-19 OA OA1200100277A patent/OA11873A/en unknown
- 2000-04-19 EP EP02080319A patent/EP1277753A1/fr not_active Withdrawn
- 2000-04-19 MX MXPA01010822A patent/MXPA01010822A/es active IP Right Grant
- 2000-04-19 HR HR20010774A patent/HRP20010774A2/hr not_active Application Discontinuation
- 2000-04-19 AR ARP000101861A patent/AR023560A1/es unknown
- 2000-04-19 AP APAP/P/2001/002329A patent/AP1607A/en active
- 2000-04-19 UA UA2001117940A patent/UA67845C2/uk unknown
- 2000-04-19 CN CNB008090548A patent/CN1152878C/zh not_active Expired - Fee Related
- 2000-04-19 EA EA200101122A patent/EA003031B1/ru not_active IP Right Cessation
- 2000-04-19 CZ CZ20013801A patent/CZ20013801A3/cs unknown
- 2000-04-19 HK HK02104877.8A patent/HK1045152A1/zh unknown
- 2000-04-19 AU AU43072/00A patent/AU4307200A/en not_active Abandoned
- 2000-04-19 SK SK1493-2001A patent/SK14932001A3/sk unknown
- 2000-04-21 MY MYPI20001706A patent/MY138673A/en unknown
- 2000-04-22 EG EG20000511A patent/EG23937A/xx active
- 2000-04-23 GC GCP2000625 patent/GC0000250A/en active
- 2000-04-24 UY UY26119A patent/UY26119A1/es not_active Application Discontinuation
- 2000-04-24 TW TW089107636A patent/TWI288749B/zh not_active IP Right Cessation
2001
- 2001-10-22 NO NO20015148A patent/NO320587B1/no unknown
- 2001-10-22 MA MA26379A patent/MA26786A1/fr unknown
- 2001-10-23 ZA ZA200108718A patent/ZA200108718B/xx unknown
- 2001-11-20 BG BG106122A patent/BG65517B1/bg unknown
2002
- 2002-03-20 AU AU27551/02A patent/AU771342B2/en not_active Ceased

Also Published As

Publication number	Publication date
WO2000064893A3 (fr)	2001-01-25
WO2000064893A2 (fr)	2000-11-02
CZ20013801A3 (cs)	2002-07-17
PL351685A1 (en)	2003-06-02
JP2002543076A (ja)	2002-12-17
KR100744361B1 (ko)	2007-07-30
BG106122A (en)	2002-05-31
TR200103060T2 (tr)	2002-05-21
AR023750A1 (es)	2002-09-04
OA11873A (en)	2006-03-27
EA003031B1 (ru)	2002-12-26
BG65517B1 (bg)	2008-10-31
HRP20010774A2 (en)	2002-10-31
GC0000250A (en)	2006-11-01
UY26119A1 (es)	2000-12-29
PE20010045A1 (es)	2001-03-10
MXPA01010822A (es)	2002-06-04
CN1355800A (zh)	2002-06-26
CA2370262A1 (fr)	2000-11-02
DZ3164A1 (fr)	2000-11-02
EP1175418A2 (fr)	2002-01-30
AU2755102A (en)	2002-05-16
UA67845C2 (uk)	2004-07-15
YU75401A (sh)	2004-09-03
SK14932001A3 (sk)	2002-02-05
NZ515167A (en)	2004-02-27
AR023560A1 (es)	2002-09-04
MY138673A (en)	2009-07-31
HUP0200937A2 (en)	2002-08-28
IL146115A0 (en)	2002-07-25
AP2001002329A0 (en)	2001-12-31
EP1277753A1 (fr)	2003-01-22
KR20010110804A (ko)	2001-12-13
BR0009935A (pt)	2002-04-16
NO20015148L (no)	2001-12-17
ZA200108718B (en)	2002-12-03
NO20015148D0 (no)	2001-10-22
CO5170419A1 (es)	2002-06-27
AU4307200A (en)	2000-11-10
CN1152878C (zh)	2004-06-09
AP1607A (en)	2006-05-03
AU771342B2 (en)	2004-03-18
EG23937A (en)	2008-01-14
EA200101122A1 (ru)	2002-04-25
NO320587B1 (no)	2005-12-27
TWI288749B (en)	2007-10-21
HUP0200937A3 (en)	2004-03-29
HK1045152A1 (zh)	2002-11-15

Publication	Publication Date	Title
MA26785A1 (fr)	2004-12-20	Nouveau produit pharmaceutique.
NL1001196A1 (nl)	1996-03-19	Nieuw farmaceutisch produkt.
MA25291A1 (fr)	2001-12-31	Livraison de produits pharmaceutiques instables.
DE60034895D1 (de)	2007-06-28	Fleischemulsionsprodukt
ATE352339T1 (de)	2007-02-15	Medikamentspender
MA26937A1 (fr)	2004-12-20	Nouvelle composition pharmaceutique.
FR2789895B1 (fr)	2006-10-06	Produit cosmetique liquide
MA26786A1 (fr)	2004-12-20	Nouveau produit pharmaceutique.
NO20030139D0 (no)	2003-01-10	Farmasöytiske preparater inneholdende DDS forbindelser
DK1200092T3 (da)	2004-08-16	Beta-carbolin-lægemiddelprodukter
MA25420A1 (fr)	2002-04-01	Cartouche pour produit alimentaire
EP1414495A4 (fr)	2005-10-26	Produit pharmaceutique chimerique de ciblage antimicrobien
IT1313579B1 (it)	2002-09-09	Composizione farmaceutica liquida a base di paracetamolo.
NO20014926L (no)	2001-12-13	Farmasöytiske forbindelser
EE200100445A (et)	2002-12-16	Suitsetatav toode
MA26783A1 (fr)	2004-12-20	Nouveau produit pharmaceutique
MA26784A1 (fr)	2004-12-20	Nouveau produit pharmaceutique.
ATE289483T1 (de)	2005-03-15	Teeprodukt
DZ2302A1 (fr)	2002-12-28	Produit pharmaceutique cristallin.
SK2926U (sk)	2001-08-06	Mäsový výrobok
MA26801A1 (fr)	2004-12-20	Complexe pharmaceutique
FR2792952B1 (fr)	2001-12-14	Nouveau produit de renforcement
FR2800360B1 (fr)	2002-01-18	Distributeur de melange de produit extemporane
DZ2159A1 (fr)	2002-12-01	Produits pharmaceutiques.
FR2791888B1 (fr)	2004-10-08	Suspension pharmaceutique buvable